Deepti Warad

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter

Michael Lim, Michael Weller, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 501 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial

Paolo A. Ascierto, Evan J. Lipson, Reinhard Dummer et al. · Journal of Clinical Oncology · 2023 · 155 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908

Ira J. Dunkel, François Doz, Nicholas K. Foreman et al. · Neuro-Oncology · 2023 · 63 citations · Full text

Medicine, Oncology, Pharmacology +11

Lemierre Syndrome: A Retrospective Study of the Role of Anticoagulation and Thrombosis Outcomes

Margaret Cupit-Link, Amulya Nageswara Rao, Deepti Warad et al. · Acta Haematologica · 2016 · 59 citations

Medicine, Hematology, Pediatrics +17

A prospective, blinded study of a PF4-dependent assay for HIT diagnosis

Bethany Samuelson Bannow, Deepti Warad, Curtis G. Jones et al. · Blood · 2020 · 48 citations · Full text

Pharmacy, Clinical Toxicology, Molecular Diagnostics +5